Steady breakthroughs and advancements in oral oncology drugs are continuing to raise hopes and improve the prognosis for millions of cancer patients. Embracing this encouraging trend, leading Community Oncologists recognize the crucial link between an effective Oral Drug Acquisition and Management strategy and the quality of cancer care ultimately delivered.
RainTree Oncology Services is offering an exciting opportunity to greatly improve efficiencies within Community Oncology practices that can result in more effective and productive patient care. Our comprehensive suite of tools and services is designed to:
- Enhance the overall revenue model within your pharmacy
- Improve operational efficiencies associated with oral drug acquisition and management
- Identify promising new therapeutic strategies relevant to oral drugs
By forging a unified oncology cooperative consisting of the nation’s foremost Community Oncology practices, RainTree is creating the dynamic framework for the future. Through collaborative networking and customized assistance, we can help you provide the most advanced therapies to your patients, while ensuring access to the leading insights and up-to-the-minute developments involving Community Oncology.
Members of the program will enjoy a wealth of benefits that include:
- Best-in-class GPO solutions
- Performance-based tracking tools
- Access to the RainTree Advisory Board
The management team of RainTree Oncology Services is comprised of respected professionals who collectively offer more than 60 years of experience that can be applied to managing the dynamic and complex issues confronting medical practices today.Michael Martin President and Chief Executive Officer/Founder
Michael Martin, whose industry experience spans more than 25 years, was President of International Oncology Network, a division of AmerisourceBergen, from 2005 to 2009. His prior experience exemplifies his broad healthcare expertise – having served as Chief Executive Officer of Tensys Medical, a venture-backed medical device company focused on non-invasive blood pressure monitoring systems, and as an Executive Vice President at Premier, the country’s largest hospital Group Purchasing Organization. Martin also previously held senior management positions at GE Medical Systems. Martin holds a BA degree from West Liberty State College.Jeff Patton, MD Chief Medical Officer/Founder
In addition to his duties with RainTree Oncology Services, Jeff Patton, MD, serves as Chief Executive Officer and Chairman of the Board for Nashville-based Tennessee Oncology, the country’s 2nd largest community oncology practice. In addition, he is the Chairman of the Oncology Committee and Chief of Staff at Southern Hills Hospital in Nashville, Tennessee. Previously, Dr. Patton served on the Physician Advisory Board for International Oncology Network, a division of AmerisourceBergen. He currently serves on the Executive Boards of the Minnie Pearl Cancer Foundation and the Leukemia and Lymphoma Society. Dr. Patton received a BA from the University of Virginia and an MD from the Eastern Virginia Medical School. Dr. Patton completed his residency and fellowship at the Bowman Gray School of Medicine in Winston-Salem, North Carolina.John Creelman Senior Vice President, Chief Financial Officer/Founder
John Creelman brings RainTree more than 20 years of senior financial management experience in large enterprises as well as emerging-growth companies. His expertise encompasses corporate finance, mergers and acquisition, and operations. Creelman has served as Chief Financial Officer for numerous early stage enterprises including ID Analytics, a provider of hosted SAAS solutions for financial services and telecomm industries, and Copper Mountain Networks, a manufacturer of DSL systems. During his tenure at Copper Mountain, he managed finance and administrative functions as revenues climbed from product launch to $290 million in just three years. Additionally, he led Copper Mountain’s successful IPO in 1999. Creelman also held senior management positions at Western Digital Corporation. Creelman holds BA and MBA degrees from the University of California at Irvine.John Dempsey President, Pharmaceutical Services
John Dempsey joins RainTree with more than 30 years of medical industry experience. During this time, he has acquired deep industry and supply chain expertise while demonstrating strong leadership and innovation in building life science companies. Before joining RainTree, Dempsey was Vice President of the Strategic Customer Group and member of the Management Board for Johnson & Johnson’s North American Pharmaceutical Business. In prior leadership positions for Ortho Biotech, Dempsey led the company’s strategic direction to ensure the safety of the Biologic supply chain. He has worked with numerous government agencies and has testified before the Surgeon General’s Task Force on Importation. He began his pharmaceutical career as a sales representative for Eli Lilly.Joe Harrington Senior Vice President, Distribution Services
Joe Harrington brings to RainTree more than 30 years of experience providing executive operations management leadership. He has successfully lead operations teams in the delivery and deployment of a broad variety of services, products and technologies from program management and deployment of high-end servers and communication equipment to providing data analytics and behavior modification systems to commercial fleet management. His expertise includes program and project management, IT/IS development teams, Business Process Outsourcing, Customer Service and Quality Assurance. Harrington served as Chief Operation Officer of AquaSpy, a provider of hosted agricultural data-analytic solutions. Harrington was also Senior Vice President of Corporate Operations at Copper Mountain Networks, a manufacturer of DSL systems. During his tenure he managed project management, operation and service deployment as revenues climbed from product launch to $290 million in just three years. Harrington also held management positions at Intel Corporation.Phillip Bradley Senior Vice President and General Counsel
Phil Bradley brings to RainTree both his experience in private practice, which focused on representing clients in the health care and pharmaceutical industries, and prior service as General Counsel. Most recently, Bradley served as Senior Vice President and General Counsel for Duane Reade, a New York-based retail pharmacy chain, where he was a member of the management team charged with transforming the face of retail pharmacy in the United States. For most of his more than 30 years of practice Bradley was with the international law firm of McKenna Long & Aldridge, serving for many years as Chair of the Litigation Department. In addition, Bradley served as General Counsel for Gentiva Health Services, North America's largest provider of home health care services. Bradley received a BA degree from St. Andrews College and received a JD degree from the Antioch School of Law.
The RainTree brain trust encompasses an eminently respected, highly influential group of professionals whose vast, collective expertise in oncology and related medical matters is respected throughout the industry.
Ongoing access to the leading insight of these industry giants ensures that RainTree will continue to develop timely solutions and highly advanced data protocols that greatly benefit physicians, practices and patients.Alberto Bessudo MD California Cancer Associates for Research and Excellence (cCARE)
Irene Lustria Regional COO, California Cancer Associates for Research and Excellence (cCARE)
Sejal S. Kuthiala MD Cancer Specialists of North Florida
Ron Thompson Chief Financial Officer, Cancer Specialists of North Florida
John Waples MD Clearview Cancer Institute
Gary Walton PharmD MBA Chief Executive Officer, Clearview Cancer Institute
William Harwin MD President & Managing Partner, Florida Cancer Specialists
Bradley Prechtl MBA Chief Executive Officer, Florida Cancer Specialists
Ray Bailey RPh Pharmacy Director, Florida Cancer Specialists
Al Soltan MD Georgia Cancer Specialists
Ron Fleming Chief Financial Officer, Georgia Cancer Specialists
Mike Method MD, MPH, MBA Michiana Hematology Oncology, PC
Kim Woofter Chief Operating Officer, Michiana Hematology Oncology, PC
Barbara McAneny MD Chief Executive Officer, New Mexico Oncology Hematology Consultants, Ltd.
Julie Nickerson MBA Director Finance/Operations, New Mexico Oncology Hematology Consultants, Ltd.
Bruce Gould MD President & Medical Director, Northwest Georgia Oncology Centers, P.C.
Scott Parker Executive Director, Northwest Georgia Oncology Centers, P.C.
David Kirlin MD President, Oncology Hematology Care
Abram Gordon Interim CEO & General Counsel, Oncology Hematology Care
Jeff Patton MD Chief Executive Officer Tennessee Oncology, Chief Medical Officer RainTree Oncology Services
Bill Alexander Chief Operating Officer, Tennessee Oncology
Stacey McCullough PharmD Director of Pharmacy, Tennessee Oncology
Barry Russo CEO, The Center for Cancer and Blood Disorders
Ray Page D.O. Ph.D. President, The Center for Cancer and Blood Disorders
William Nibley MD President, Utah Cancer Specialists
Walt Moyer CEO, Utah Cancer Specialists